- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07937267
Cytological Assessment of Donor-Site Healing After Free Gingival Grafting
Cytological Evaluation of the Effects of Different Donor-Site Interventions on Healing After Free Gingival Graft Surgery
An adequate width of keratinized gingiva is important for maintaining periodontal and peri-implant tissue health. Free gingival grafting (FGG) is a commonly performed surgical procedure for increasing insufficient keratinized gingival width. This study aims to evaluate the effect of applying a chitosan sponge to the palatal donor site on wound healing after FGG using exfoliative cytology and to compare the findings with those obtained from a control group in which no chitosan sponge is applied.
At least 40 patients scheduled to undergo FGG because of insufficient keratinized gingival width will be included. The patients will be allocated to two groups: a test group and a control group. In the test group, a chitosan sponge will be applied to the palatal donor site, whereas no wound dressing will be applied to the palatal donor site in the control group. The primary outcome will be the keratinization index determined from cytological samples collected from the palatal donor site at one month after surgery. The keratinization index values at one month will be compared between the test and control groups.
All participants will receive detailed information about the study and the procedures, and written informed consent will be obtained. Clinical measurements will be recorded before surgery, after which the FGG procedure will be performed. Depending on group allocation, the palatal donor site will either be treated with a chitosan sponge or left without a wound dressing. Sutures will be removed on postoperative day 10.
For exfoliative cytological assessment, baseline samples will be collected from both the planned palatal donor site and the contralateral symmetrical healthy palatal site, which will not undergo surgery, in all patients. Samples collected from the symmetrical palatal site will serve as a reference for the baseline characteristics of healthy palatal mucosa. Follow-up samples will be collected exclusively from the palatal donor site on postoperative day 3,10 and at 1, 3, and 6 months. The keratinization index and other cellular features associated with wound healing will be assessed in the cytological samples. Findings obtained during the follow-up periods will be compared between the test group treated with a chitosan sponge and the control group in which no wound dressing is applied. In addition, the presence or absence of sensory loss at the palatal donor site will be evaluated using a periodontal probe.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
Istanbul, Turkije (Türkiye)
- Werving
- Biruni University
-
Contact:
- Ayşe Ege Selman
- Telefoonnummer: 902124448276
- E-mail: ayseegeselman@gmail.com
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Volunteering to participate in the study,
- Being at least 18 years of age,
- The need for SDG in patients with < 2 mm of keratinized gingiva on the vestibular side of the implant/tooth,
- No prior surgical procedures or grafts in the palatal region,Volunteering to participate in the study,
Exclusion Criteria:
- The presence of a systemic disease that would contraindicate surgical treatment,
- Uncontrolled diabetes (HbA1c > 7),
- Pregnancy or breastfeeding,
- Autoimmune and/or inflammatory diseases of the oral cavity,
- Active periodontal disease.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Actieve vergelijker: Controle
|
Free gingival graft surgery |
|
Experimenteel: Test
|
Free gingival graft surgery Suturing of chitosan sponge to the palatal donor site |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Palatal donor site tissue thickness:
Tijdsspanne: Pre-operative
|
The thickness of the donor site will be measured using an endodontic reamer. |
Pre-operative
|
|
Palatal donor site tissue thickness:
Tijdsspanne: immediate Post-operative
|
The thickness of the donor site will be measured using an endodontic reamer. |
immediate Post-operative
|
|
Palatal donor site tissue thickness:
Tijdsspanne: day 10
|
The thickness of the donor site will be measured using an endodontic reamer. |
day 10
|
|
Palatal donor site tissue thickness:
Tijdsspanne: day 30
|
The thickness of the donor site will be measured using an endodontic reamer. |
day 30
|
|
Palatal donor site tissue thickness:
Tijdsspanne: day 90
|
The thickness of the donor site will be measured using an endodontic reamer. |
day 90
|
|
Palatal donor site tissue thickness:
Tijdsspanne: day 180
|
The thickness of the donor site will be measured using an endodontic reamer. |
day 180
|
|
Keratinization Index
Tijdsspanne: day 3
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 3
|
|
Keratinization Index
Tijdsspanne: day 10
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 10
|
|
Keratinization Index
Tijdsspanne: day 30
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 30
|
|
Keratinization Index
Tijdsspanne: day 90
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 90
|
|
Keratinization Index
Tijdsspanne: day 180
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 180
|
|
Superficial cell index
Tijdsspanne: day 3
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 3
|
|
Superficial cell index
Tijdsspanne: day 10
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 10
|
|
Superficial cell index
Tijdsspanne: day 30
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 30
|
|
Superficial cell index
Tijdsspanne: day 90
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 90
|
|
Superficial cell index
Tijdsspanne: day 180
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 180
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Loss of sensation
Tijdsspanne: Day 10
|
To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping. |
Day 10
|
|
Loss of sensation
Tijdsspanne: Day 30
|
To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping. |
Day 30
|
|
Loss of sensation
Tijdsspanne: Day 90
|
To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping. |
Day 90
|
|
Loss of sensation
Tijdsspanne: Day 180
|
To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping. |
Day 180
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- 2015-KAEK-80-23-44
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .